Q1 2010 Canadian Healthcare Review...

Financing Public Canadian healthcare companies completed equity and convertible debt financings during this quarter for total gross proceeds of $236.0 million (Appendix 1). The largest financing in the sector was the only financing in the Services group, $86.3 million by Extendicare. The largest financing in the Therapeutics group was $34.5 million from a rights offering by Wex Pharmaceuticals, with 97.6% of the shares being...

CEOs Speak Out About Issues Affecting Their Abilit...

By Gail Garland In the summer of 2009, the CEOs of Ontario’s SME bioscience companies came together at the open invitation of Ontario Bioscience Industry Organization (OBIO) for a meeting hosted in Gowlings Toronto boardroom. On the agenda was a discussion of the future of Ontario’s bioscience industry and its unprecedented lack of access to capital, a worsening situation threatening the sustainability of the...

Discussion Notes: Quebec/Ontario Bioscience CEO Di...

What Quebec/Ontario Government funded programs are most effective? First and foremost, as entrepreneurs our duty is to create shareholder wealth with products and services the marketplace demands.  This cannot be substituted with or diverted by any government funding program. Quebec:  Tax holidays for key employees; tax exemption for new products developed in Quebec Quebec’s SR&ED tax credit regime is a...

BURRILL CANADIAN BIOTECH NEWS...

“The Ontario Government is listening to our industry and recognizing the economic potential of a vibrant and growing bioscience industry that can produce many of the medical therapies and technologies we now import and can create jobs”, said Dr. David Young, chair of the board of directors of OBIO, and managing partner, Actium Equity Partners. View PDF: ...

Bioscience industry applauds Ontario government fo...

Budget boost, changes to funding programs should improve access to capital  TORONTO, March 26 – Urgently needed capital should become more accessible to Ontario’s bioscience companies and help create jobs in the biotechnology sector, thanks to Ontario’s 2010 budget.  An announced increase in the budget of the Ministry of Research and Innovation coupled with anticipated adjustments to existing funding programs designed...